A reference to lab values, and to who sets the targetsHow we verifyHidden costsDealsAbout
OptimizeBiomarkers

Sources/Institution or study

Yamada et al. 2011 (J Diabetes Investig), CLSI-based reference interval in a healthy Japanese population

Named as the source for 1 optimal-range position across 1 biomarker on this site. How we verify ranges.

01

Every position on this site

One row per marker. The comparison column uses the same simple-range parser the rest of the site does, so it is left blank rather than guessed when a range is tiered, sex-split, or in a different unit than the lab interval.

MarkerTheir rangeVs. the lab reference intervalWhere they stated it
HOMA-IR (Insulin Resistance)0.4-2.4 (healthy-population reference interval)not directly comparableCited document ↗2,153 subjects aged 20-79 with fasting glucose <100 mg/dL, BMI <25 and normal ALT; the mean ± 2 SD of log HOMA-IR gave a reference interval of 0.4-2.4. The authors call HOMA-IR ≥ 2.5 a reasonable indicator of insulin resistance in this population

1 verified position shown. Every row above either links to the optimal-ranges document named in our biomarker data or passed the expert-range verification described here; unverified or withheld claims never render.

Not medical advice. © 2026 Ocean Path Ventures LLC.

The monthly dispatch

Price changes, new sources, corrected ranges.

Once a month. Every change we made to the site, and why.